<!– Click –>

Does this mean we are without our losses? HECK NO! No one, not even MarijuanaStocks.com is without a share of losers as well. Have we had far more wins than losses? HECK YES! Consistency is what matters and within a sector still growing and finding its stable footing, MarijuanaStocks.com has been and will continue to be a consistent rock for all who are interested in the budding cannabis Space.

GT Biopharma, Inc. (GTBP) (previously OXIS International) is a biotech company that has utilized CBD in an attempt to treat various forms of cancer & we have proudly worked with them since 2014. (GTBP) has consistently delivered double and even triple digit gains for our members year after year for the past 4 years! As we said above consistency is key. As you can see from the chart below GT Biopharma, Inc. (GTBP) appears to be setting up for what looks like another break-out run & in our opinion is one you want to keep on your radar.

We encourage all who have an interest in GT Biopharma, Inc. (GTBP) to check out their official Company Overview for July 2018 by clicking here.

It’s important to note that just because past results we’re good with a company does not mean future results will be. GT Biopharma, Inc. (GTBP) is a penny stock and all penny stocks can and often are volatile. We encourage EVERYONE to do their own research and make their own decisions & please read our full disclaimer here.

In our opinion, Leafbuyer Technologies, Inc. (LBUY) provides a unique opportunity for those interested in the innovation, technology and consumer side of the Cannabis Industry. According to (LBUY) they are the largest cannabis-deals network in the USA with 5 million active users that have saved millions of dollars on all types of Cannabis products using their website LeafBuyer.com.

As the end of Prohibition for the Marijuana / Cannabis Industry continues it is expected that the need for companies like Leafbuyer Technologies, Inc. (LBUY) that give power & savings to the consumer will be more and more in demand and commonplace.

Check out our article titled “Marijuana Prohibition is Ending & Opportunity is Beginning” here we outline in more detail the opportunity we believe is present within the Marijuana industry & Leafbuyer Technologies, Inc. (LBUY) (Click Here)

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 NOW EXTENDED TO 10/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Read Our Full Disclaimer Here

We’ve brought attention back to a repeat winner that we’ve covered for the better part of the last 4 years.  Those of you who have been with us for a little while, you will surely remember OXIS International, now trading under the symbol (GTBP) we have once again begun to follow progress in the market. With past numerous examples of frequent breakouts, we once again see (GTBP) in appearing ready to break out.

Each time (GTBP) has pulled back to monthly lows, the market has responded positively and with recent news of the company’s CMO being promoted to CEO and Chairman of the Board, sentiment could continue to remain very positive.

As you can see, (GTBP) has once again begun to break out.  The last time it did this, (GTBP) managed to rally to highs of over $2.70!  Could this be in store once again? Well, as of today, we’ve not only seen (GTBP) rally 20% on an intra-day time frame but over the last 5 trading sessions, (GTBP) has moved up by as much as 53%!  In our strong opinion, this could once again be the first sign of a much longer-term bull run.

We saw it back in June, we saw a “mini-rally” back in May, and we saw a test of the $2.25 level when (GTBP) ran in April. Ultimately it comes down to the fundamentals and with the small-cap biotech segment of the market taking much of the spotlight this year, 2018’s second half could be primed for companies like this to capitalize on the overall market momentum.

DISCLAIMER:
An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Full Disclaimer Here

When investing one can never make assumptions. Investors must complete extensive due diligence before participating in the buying or selling of any security. It is important to look for proven management teams, serious scientific information and solid drug candidate development plans before investing in any biotech company.

The information in this article is historical fact and accurate stock market data. When considering investments in development stage companies as individual investors we must make certain we do not fall prey speculative, misleading or any information brazenly hyping the stock of any individual company.